Hello,
On occasion when a patient's response to an infusion is not as expected, providers have requested potency testing (eg. alprostadil, bivalirudin). Potency testing is useful to rule out dispensing errors, but not other causes. We are hoping to develop a process to review potential infusion errors, including sequestering the device and medication/tubing, review pump data, review patient case, etc.
Does anyone have a process and/or policy to investigate potential errors with smart infusion pumps? Thank you!